dromostanolone has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beskrovnyĭ, AM; Iurchenko, MZ; Sof'ina, ZP; Sukhacheva, OA; Ushenko, SN | 1 |
| Bowie, M; Budinger, JM; Chou, TC; Stock, CC; Teller, MN | 1 |
2 other study(ies) available for dromostanolone and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
[Experimental study of an antitumor preparation proloteston].
Topics: Androstanols; Animals; Antineoplastic Agents; Drug Therapy, Combination; Female; Mammary Neoplasms, Experimental; Melphalan; Rats | 1983 |
Therapy of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas with combinations of 5-fluorouracil and 2 alpha-methyldihydrotestosterone propionate.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstanols; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluorouracil; Mammary Neoplasms, Experimental; Mice | 1982 |